| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC3098 | |||||||||||||||||||||||
| Submitter : | Mrs. Camilla Arthur | Date & Time: | 12/14/2006 11:12:14 | |||||||||||||||||||||
| Organization : | Mrs. Camilla Arthur | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I am absolutely opposed to the use of aborted fetal cell lines for future vaccine development. Alternative vaccines can be prepared. | ||||||||||||||||||||||||